ION-356

N/A

Report date: 2024/04/26 20:00:28
NME

Base Information

Drug NameION-356
Drug Alias NameION-356
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGene silencingMyelin proteolipid protein inhibitors
TargetsMyelin proteolipid protein
Therapy Area/IndicationsPelizaeus-Merzbacher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsGermany +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPelizaeus-Merzbacher Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A